Intelligence / Healthtech / New Clinical Trials / Odyssey Therapeutics, Inc.
Clinicaltrial registered28 Oct 2026
Odyssey Therapeutics, Inc.
28 Oct 2026: Trial registered · The Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]OD-001 in Healthy Male Participants. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 28 Oct 2026
- Title
- The Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]OD-001 in Healthy Male Participants
- Conditions
- Health Volunteers
- Phase
- Phase 1
- Study Type
- Interventional
- Status
- Recruiting
- Countries
- United Kingdom
- Country
- United Kingdom
- Reference
- NCT07900607
- Location
- United Kingdom
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Odyssey Therapeutics, Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
More from United Kingdom
New Clinical Trials
16 NovBiosensors Europe SAtrial registered · Study of the BioRISE Biolimus Drug-Coated Balloon Versus the SELUTION SLR Sirolimus-Coated Balloon in De Novo Coronary Lesions, With a Single-Arm In-Stent Restenosis Cohort (SUNRISE)Clinical12 NovMSK Doctors & Associates Ltdtrial registered · Electrical Muscle Stimulation (EMS) Versus Standard Physiotherapy for Quadriceps Recovery Following Total Knee ReplacementClinical12 NovNovo Nordisk A/Strial registered · A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or BothClinical12 NovNovo Nordisk A/Strial registered · AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or BothClinical10 NovEli Lilly and Companytrial registered · A Study of Brenipatide in Participants With Major Depressive DisorderClinical10 NovEli Lilly and Companytrial registered · A Study of LY4336619 in Adult Participants With Advanced Solid TumorsClinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.